Table 2.
Androgen precursors | Women | Men | Androgen metabolites | Women | Men |
---|---|---|---|---|---|
DHEA | 4.2–11.8a | 6.9–30c | Androsterone (AST) | 0.4–2.1c | 0.9–1.9c |
6.3–35.4c | 15.8g | 0.5 ± 0.03d | 0.7 ± 0.03d | ||
3.4 ± 0.03d | 4.1 ± 0.1d | AST-sulfate | ndd | 19 ± 1.6d | |
10–20j | 1250–2500j | ||||
DHEA sulfate | 3400–9600a | 1312–14125c | AST-glucuronide | 28–467c | 59–248c |
701–8965c | 5709g | 89 ± 0.7d | 104 ± 1.4d | ||
3337 ± 16d | 3247 ± 50d | 2.1–170e | 86–150h | ||
4300–5400j | EpiAST | 0.6 ± 0.03d | 0.3 ± 0.02d | ||
A4 | 3.3–9.2a | 2.3–5.5c | EpiAST-sulfate | 123±3d | 105 ± 3.2d |
1.2–2.82b | 3.64g | 500–850j | |||
1.1–8.7c | EpiAST-glucuronide | 78 ± 0.4d | 76 ± 1.3d | ||
5-androstenediol (5-diol) | 1.5 ± 0.07d | 1.7 ± 0.2d | 3α-androstanediol (3α-adiol) |
nqd | 0.2 ± 0.02d |
5-diol-sulfate | 215 ± 21d | 178 ± 10d | 3α-adiol-sulfate | ndd | ndd |
250–500j | 3α-adiol-3-glucuronide | 0.6–8.4c | 1.3–6.7c | ||
5α-androstanedione | 0.5–2.6c | 1.0–1.5c | 0.5–9.2e | 2.0–3.8h | |
11OHA4 | 4.9–12.5a | 2.3–5.1i | 3α-adiol-17-glucuronide | 0.3–10c | 6.2–8.8c |
11KA4 | 2–3.9a | 0.7–1.4i | 0.5–12e | 5.4–11h | |
11OHT | 0.1–0.3a | 0.3–0.7i | DHEA-glucuronide | 0.9 ± 0.001d | 0.7 ± 0.03d |
7αOH-DHEA | 0.08–1.4f | ||||
Active Androgens | 7βOH-DHEA | 0.08–0.9f | |||
T | 0.2–0.5a | 7.4–14c | 7-oxo-DHEA | 0.03–0.6f | |
0.58–1.1b | 16.85g | 16OH-DHEA-sulfate | 100–200j | ||
0.4–4.1c | 15.6 ± 0.6d | T-sulfate | ndd | ndd | |
1.1 ± 0.09d | 10–20j | T-glucuronide | 0.8 ± 0.02d | 26.5 ± 0.1d | |
Calculated free T | 0.0056–0.0122b | 0.3780g | DHT-sulfate | 0.3–2.7c | 2.5–3.5c |
DHT | 0.2–0.9c | 0.9–2c | ndd | ndd | |
0.4–0.01d | 1.2 ± 0.09d | DHT-glucuronide | ndd | ndd | |
11KT | 1.2–1.8a | 1.0–2.6i | 5-diol-glucuronide | nqd | nqd |
O'Reilly et al. (2016), interquartile range, n = 49, age interquartile range 23–32.
Haring et al. (2012), interquartile range, n = 985, age 20-80.
Trabert et al. (2016), min-max, pre- and postmenopausal women, n = 15.
Zang et al. (2017), mean ± standard deviation for triplicate of pooled commercial serum.
Labrie et al. (2006), min-max, pre- and postmenopausal women, n = 424.
Ke et al. (2016), min-max, pre- and postmenopausal women, n = 34.
Damgaard-Olesen et al. (2016), geometric mean, n = 72, age 30-<40.
Vandenput et al. (2007), interquartile range, n = 1086, age interquartile range 18.4–19.3.
Turcu et al. (2016), interquartile range, combined values for 19 men and 19 women, age 3-59.
Sanchez-Guijo et al. (2016), interquartile range estimated from Fig. 2, n = 60, age range 18–60.